Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Preferred Equity

Amneal Pharmaceuticals Inc Preferred Equity Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Preferred Equity from 2019 to 2019.
Other Balance Sheet Metrics:
  • Amneal Pharmaceuticals Inc Total Assets for the quarter ending December 12, 2018 was $4,353m a 68.78% increase of 2,994m year over year
  • Amneal Pharmaceuticals Inc Other Liabilities for the quarter ending December 12, 2018 was $233m a 90.39% increase of 210m year over year
  • Amneal Pharmaceuticals Inc Total Equity for the quarter ending December 12, 2018 was $896m a 141.15% increase of 1,265m year over year
View Chart On Koyfin